Correlation of Serum 3α-Androstanediol Glucuronide with Acne and Chest Hair Density in Men

Serum 3 alpha-androstanediol glucuronide (3 alpha-Adiol-G) is considered to be an indicator of peripheral tissue androgen metabolism. Precursor circulating androgens are converted in peripheral tissue to dihydrotestosterone (DHT), which is ultimately metabolized to 3 alpha-Adiol-G and secreted from the cell. Elevated serum 3 alpha-Adiol-G concentrations have been reported in women in hyperandrogenic states. We studied 44 consecutive male medical students for chest hair density, acne, and serum dehydroepiandrosterone sulfate (DHEA-S), total testosterone (total T), free and albumin-bound (bioavailable) T (bio T), and 3 alpha-Adiol-G concentrations. Although there was considerable overlap of serum 3 alpha-Adiol-G values among the groups defined by hair density or acne scores, we found statistically significant correlations between serum 3 alpha-Adiol-G and chest hairiness (P = 0.0034), acne (P = 0.0005), and a combined chest hairiness and acne score (P = 0.0018). There was no significant correlation between these clinical parameters and the levels of precursor androgens. There was, however, a strong correlation between serum 3 alpha-Adiol-G and bio T (P = 0.0005), suggesting that in men serum 3 alpha-Adiol-G levels may be dependent upon available free and albumin-bound T. The correlations in men of serum 3 alpha-Adiol-G with chest hair density, acne, and the hairiness and acne index supports the hypothesis that the serum levels of 3 alpha-Adiol-G reflect the extent of androgen action in peripheral tissues.

[1]  M. Kirschner,et al.  Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism. , 1987, The Journal of clinical endocrinology and metabolism.

[2]  R. Lobo,et al.  Measurements of 3α, 17(β-androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity , 1986 .

[3]  P. Mauvais-Jarvis,et al.  7 Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women , 1986 .

[4]  A. Bélanger,et al.  Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. , 1986, The Journal of clinical endocrinology and metabolism.

[5]  W. Cefalu,et al.  Bioavailability of albumin-bound testosterone. , 1985, The Journal of clinical endocrinology and metabolism.

[6]  R. Santen,et al.  Tissue production of androgens in women with acne. , 1985, Journal of the American Academy of Dermatology.

[7]  R. Horton,et al.  Origin of plasma androstanediol glucuronide in men. , 1984, The Journal of clinical endocrinology and metabolism.

[8]  W. Cunliffe,et al.  The Relationship Between the In Vitro Activity of 3β-Hydroxysteroid Dehydrogenase Δ4–5-Isomerase in Human Sebaceous Glands and Their Secretory Activity In Vivo , 1983 .

[9]  R. Horton,et al.  Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. , 1983, The Journal of clinical endocrinology and metabolism.

[10]  S. Marynick,et al.  Androgen excess in cystic acne. , 1983, The New England journal of medicine.

[11]  I. Mowszowicz,et al.  Dihydrotestosterone Stimulates 5a-Reductase Activity in Pubic Skin Fibroblasts* , 1983 .

[12]  R. Horton,et al.  3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. , 1982, The Journal of clinical investigation.

[13]  S. Itami,et al.  Activity of 17β‐hydroxysteroid dehydrogenase in various tissues of human skin , 1981 .

[14]  A. Edmiston,et al.  Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men. , 1981, The Journal of clinical endocrinology and metabolism.

[15]  J. Burton,et al.  Male‐pattern alopecia and masculinity , 1979, The British journal of dermatology.

[16]  R. Santen,et al.  Adrenal suppression with aminoglutethimide. I. Differential e-fects of aminoglutethimide on glucocorticoid metabolism as a rationale for use of hydrocortisone. , 1977, The Journal of clinical endocrinology and metabolism.

[17]  R. Tremblay,et al.  Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. , 1974, Contraception.

[18]  M. Hodgins,et al.  Metabolism of androgens by human skin in acne , 1974, The British journal of dermatology.

[19]  P. Mauvais-Jarvis,et al.  Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. , 1973, The Journal of clinical endocrinology and metabolism.

[20]  G. Sansone,et al.  Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin--a possible pathogenic factor in acne. , 1971, The Journal of investigative dermatology.

[21]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[22]  R. Horton,et al.  Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women. , 1986, The Journal of clinical endocrinology and metabolism.

[23]  D. Mishell,et al.  Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. , 1981, The Journal of clinical endocrinology and metabolism.

[24]  J. Buster,et al.  Radioimmunoassay of Plasma Dehydroepiandrosterone Sulfate , 1972 .